BioHealth News

TEDCO Announces Graham Dodge as the New Vice President, Innovation Connectors

TEDCO Announces Graham Dodge as the New Vice President, Innovation Connectors

COLUMBIA, Md., (July 11, 2024) — TEDCO, Maryland’s economic engine for technology companies, announces the appointment of Graham Dodge as the vice president of…

Read More
Activation Capital’s President and CEO Announces Departure

Activation Capital’s President and CEO Announces Departure

RICHMOND, Va., July 8, 2024 – Activation Capital, an innovation ecosystem development organization, announced today that Chandra Briggman, president and chief executive officer of Activation…

Read More
Axios – How AI is driving the venture capital market

Axios – How AI is driving the venture capital market

Artificial intelligence is keeping the venture capital ecosystem afloat. It accounted for more than 40% of new private U.S. "unicorns" in the first half this year,…

Read More
Emergent, J&J settle COVID vaccine supply deal dispute

Emergent, J&J settle COVID vaccine supply deal dispute

July 8 (Reuters) - Emergent BioSolutions (EBS.N), opens new tab said on Monday Johnson & Johnson (JNJ.N), opens new tab has agreed to pay $50 million to settle…

Read More
Elevate Your Startup: Apply to Compete in the 9th Annual Crab Trap Competition

Elevate Your Startup: Apply to Compete in the 9th Annual Crab Trap Competition

Are you ready to showcase your company to some of the top minds in the industry? The 9th Annual Crab Trap competition, a highlight…

Read More
Arlington’s Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions

Arlington’s Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions

ARLINGTON, Va.--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection,…

Read More
Ascentage Pharma Received US$100 Million Option Payment from Takeda

Ascentage Pharma Received US$100 Million Option Payment from Takeda

ROCKVILLE, Md. and SUZHOU, China, July 3, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies…

Read More
Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics

Sirnaomics Announces Interim Results for Successful Completion of the Second Cohort of Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Therapeutics

HONG KONG and GERMANTOWN, Md. and SUZHOU, China, July 8, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical…

Read More
Maryland Awards $500K to Early Charm Ventures for Biomanufacturing Incubator at Harford County Facility

Maryland Awards $500K to Early Charm Ventures for Biomanufacturing Incubator at Harford County Facility

BEL AIR, Md., (July 1, 2024) – Maryland Department of Commerce has awarded $500K to Baltimore-based Early Charm to develop a biomanufacturing incubator at a…

Read More
Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than $250 million in contract modifications from the Administration for Strategic…

Read More
EDA: Biden-Harris Administration Announces Next Funding Round of $504 Million for 12 Tech Hubs Across America

EDA: Biden-Harris Administration Announces Next Funding Round of $504 Million for 12 Tech Hubs Across America

WASHINGTON, DC — The Biden-Harris Administration, through the U.S. Department of Commerce’s Economic Development Administration (EDA), announced another funding round of approximately $504 million in implementation…

Read More
Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for…

Read More
Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

Cartesian Therapeutics Announces Positive Topline Results from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering mRNA cell…

Read More
TJP: 2023 Crab Trap Finalist EyeControl creates revolutionary medical technology

TJP: 2023 Crab Trap Finalist EyeControl creates revolutionary medical technology

EyeControl improves clinical outcomes, prevent cognitive decline, and enhance the patient and family experience.“We are honoured to be able to support every patient –…

Read More
From Tunisia to Maryland: FluoInk’s Journey at the SelectUSA Investment Summit

From Tunisia to Maryland: FluoInk’s Journey at the SelectUSA Investment Summit

Professor Ramzi Maalej, CTO and Founder of FluoInk, recently traveled from Tunisia to Maryland to attend the SelectUSA Investment Summit. FluoInk is currently working…

Read More